Inventor · disambiguated record
Alina Silina
Also filed as: SILINA ALINA
24 granted patents·20 pending applications·577 citations·filing 2005–2024
96Inventor score
Top patents by PatentIndex Score
44 records- 0198US8785640B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2013·Granted Jul 22, 2014·72 cites·35 claims
- 0298US8598205B2Modulators of cystic fibrosis transmembrane conductance regulatorBINCH HAYLEY·Filed 2012·Granted Dec 3, 2013·77 cites·22 claims
- 0398US8513282B2Modulators of cystic fibrosis transmembrane conductance regulatorBINCH HAYLEY·Filed 2009·Granted Aug 20, 2013·84 cites·11 claims
- 0497US10758534B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2019·Granted Sep 1, 2020·13 cites·38 claims
- 0597US10258624B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2017·Granted Apr 16, 2019·32 cites·47 claims
- 0697US9782408B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2015·Granted Oct 10, 2017·33 cites·84 claims
- 0797US8614327B2Modulators of ATP-binding cassette transportersVERTEX PHARMA·Filed 2012·Granted Dec 24, 2013·78 cites·9 claims
- 0897US8410112B2Compounds useful as inhibitors of ATR kinaseCHARRIER JEAN-DAMIEN·Filed 2011·Granted Apr 2, 2013·56 cites·71 claims
- 0996US11426407B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2020·Granted Aug 30, 2022·6 cites·47 claims
- 1095US12421251B2Cystic fibrosis transmembrane conductance regulator modulating agentsVERTEX PHARMA·Filed 2020·Granted Sep 23, 2025·5 cites·25 claims
- 1194US8802700B2Modulators of ATP-Binding Cassette transportersSHETH URVI·Filed 2012·Granted Aug 12, 2014·74 cites·5 claims
- 1293US12168009B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2022·Granted Dec 17, 2024·1 cites·46 claims
- 1391US10738030B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2017·Granted Aug 11, 2020·6 cites·48 claims
- 1490US7858635B2Spiro compounds as modulators of muscarinic receptorsVERTEX PHARMA·Filed 2006·Granted Dec 28, 2010·24 cites·19 claims
- 1588US2025205232A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2024·Application pending·0 cites
- 1687US8497295B2Spiroindoline modulators of muscarinic receptorsMAKINGS LEWIS R·Filed 2012·Granted Jul 30, 2013·10 cites·22 claims
- 1776US7880007B2Bicyclic substituted phenyl piperidine modulators of muscarinic receptorsVERTEX PHARMA·Filed 2005·Granted Feb 1, 2011·3 cites·7 claims
- 1874US7786141B2Dihydrospiroindene modulators of muscarinic receptorsVERTEX PHARMA·Filed 2006·Granted Aug 31, 2010·1 cites·2 claims
- 1971US7879834B2Spiroindoline modulators of muscarinic receptorsVERTEX PHARMA·Filed 2005·Granted Feb 1, 2011·1 cites·31 claims
- 2069US8263605B2Modulators of muscarinic receptorsMAKINGS LEWIS R·Filed 2007·Granted Sep 11, 2012·1 cites·18 claims
- 2162US2014303204A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2014·Application pending·0 cites
- 2258US2013281476A1Modulators of Muscarinic ReceptorsVERTEX PHARMA·Filed 2013·Application pending·0 cites
- 2358US2013158071A1Pharmaceutical compositions and administrations thereofVERTEX PHARMA·Filed 2012·Application pending·0 cites
- 2457US2013131107A1Pharmaceutical compositions and administrations thereofVERTEX PHARMA·Filed 2012·Application pending·0 cites
- 2556US8367691B2Modulators of muscarinic receptorsVERTEX PHARMA·Filed 2010·Granted Feb 5, 2013·0 cites·5 claims
- 2656US2023382924A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 2756US2023416275A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 2856US2023373974A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 2956US2023382925A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 3056US2023373939A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 3156US2023373935A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 3256US2023365587A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 3356US2024018161A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 3456US2023374038A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 3556US2024150377A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 3655US9181273B2Morpholine-spirocyclic piperidine amides as modulators of ion channelsVERTEX PHARMA·Filed 2014·Granted Nov 10, 2015·0 cites·21 claims
- 3754US2014343098A1Modulators of atp-binding cassette transportersVERTEX PHARMA·Filed 2014·Application pending·0 cites
- 3852US2016022665A2Pharmaceutical Compositions and Administrations ThereofVERTEX PHARMA·Filed 2015·Application pending·0 cites
- 3951US8258148B2Spiroindoline modulators of muscarinic receptorsMAKINGS LEWIS R·Filed 2010·Granted Sep 4, 2012·0 cites·29 claims
- 4051US2016022664A2Pharmaceutical Compositions and Administrations ThereofVERTEX PHARMA·Filed 2015·Application pending·0 cites
- 4149US8828996B2Morpholine-spirocyclic piperidine amides as modulators of ion channelsHADIDA-RUAH SARA SABINA·Filed 2012·Granted Sep 9, 2014·0 cites·79 claims
- 4249US2014113005A1Compounds useful as inhibitors of atr kinaseVERTEX PHARMA·Filed 2013·Application pending·0 cites
- 4346US10233191B2Fused piperidine amides as modulators of ion channelsVERTEX PHARMA·Filed 2014·Granted Mar 19, 2019·0 cites·32 claims
- 4439US2011257223A1Modulators of Cystic Fibrosis Transmembrane Conductance RegulatorVERTEX PHARMA·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →